There were 1,875 press releases posted in the last 24 hours and 400,003 in the last 365 days.

Stericycle, Inc. Reports Results for the Fourth Quarter and Full Year Ended 2015

LAKE FOREST, Ill., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Stericycle, Inc. (NASDAQ:SRCL) today reported financial results for the fourth quarter and the full year of 2015.

FOURTH QUARTER RESULTS
Revenues for the quarter ended December 31, 2015 were $888.3 million, up $211.4 million or 31.2%, from $676.9 million in the fourth quarter last year. Acquisitions contributed approximately $200.0 million in revenues to the current period’s growth. Revenues increased 35.2% compared to the prior period when adjusted for unfavorable foreign exchange impact of $26.9 million.

Gross profit, reported in accordance with U.S. generally accepted accounting principles (“GAAP”), was $380.4 million, up 33.5% from $285.0 million in the fourth quarter last year. GAAP gross profit as a percent of revenues was 42.8% compared to 42.1% in the fourth quarter last year. Non-GAAP gross profit, when adjusted for various items identified in the second of the following tables, was $380.9 million, up 33.5% from $285.4 million in the fourth quarter last year. Non-GAAP gross profit as a percent of revenues was 42.9% compared to 42.2% in the fourth quarter last year.

GAAP earnings per diluted share decreased 16.4% to $0.80 from $0.96 in the fourth quarter last year. Non-GAAP earnings per diluted share, when adjusted for various items identified in the third of the following tables, decreased 0.9% to $1.11 from $1.12 in the fourth quarter last year. See tables below.

FULL-YEAR RESULTS
Revenues for the full year 2015 were $2.99 billion, up $430.3 million or 16.8%, from $2.56 billion in the same period last year. Acquisitions contributed approximately $378.5 million in revenues to the current year’s growth. Revenues increased 21.2% compared with the prior period when adjusted for unfavorable foreign exchange impact of $110.2 million.

GAAP gross profit was $1.27 billion, up 15.7% from $1.09 billion in the same period last year. GAAP gross profit as a percent of revenues was 42.4% compared to 42.8% in the same period last year. Non-GAAP gross profit, when adjusted for various items identified in the second of the following tables, was $1.27 billion, up 15.5% from $1.10 billion in the same period as last year. Non-GAAP gross profit as a percent of revenues was 42.5% compared to 42.9% in the same period last year.

GAAP earnings per diluted share decreased 21.7% to $2.96 from $3.79 in 2014. Non-GAAP earnings per diluted share, when adjusted for various items identified in the third of the following tables, increased 3.0% to $4.40 from $4.27. See tables below.

The following table shows our calculations of organic revenue growth (in millions)(1)

  Three Months Ended December 31,   Years Ended December 31,
      Change       Change
    2015     2014   $ %     2015     2014   $ %
Total As Reported Revenues (GAAP) $   888.3   $   676.9   $   211.4     31.2 %   $ 2,985.9   $ 2,555.6   $   430.3     16.8 %
Adjustment for Foreign Exchange   26.9       26.9         110.2       110.2    
Subtotal (non-GAAP):   915.2     676.9     238.2     35.2 %     3,096.1     2,555.6     540.5     21.2 %
                   
Adjustment for Acquisitions   (206.6 )   (6.7 )   (200.0 )       (439.1 )   (60.6 )   (378.5 )  
Adjustment for Regulated Returns and
Recall Management Services
  (20.4 )   (16.1 )   (4.4 )       (87.4 )   (80.5 )   (7.0 )  
Total revenues, as adjusted (non-GAAP): $  688.1   $  654.2   $  33.9     5.2 %   $ 2,569.6   $ 2,414.5   $   155.1     6.4 %
                   
Domestic/ International Breakdown:                  
Domestic Revenues $ 651.1   $ 477.6   $ 173.5     36.3 %   $ 2,165.0   $ 1,788.4   $ 376.6     21.1 %
International Revenues   237.2     199.3     37.9     19.0 %     820.9     767.2     53.7     7.0 %
Total As Reported Revenues (GAAP) $   888.3   $   676.9   $   211.4     31.2 %   $ 2,985.9   $ 2,555.6   $   430.3     16.8 %

(1) For internal purposes, we exclude the impact of foreign exchange, revenues attributed to acquisitions closed within the preceding 12 months, and revenue from our regulated returns and recall management services when we evaluate organic revenue growth.

This table and the Company’s internal use of non-GAAP adjusted revenues are not intended to imply, and should not be interpreted as implying, that non-GAAP adjusted revenues are a better measure of internal growth or the Company’s performance, as compared to GAAP revenues.

Table to reconcile GAAP Gross Profit to Non-GAAP Gross Profit (in millions)(2)

  Three Months Ended December 31,   Years Ended December 31,
    2015       2014       2015       2014  
  $ % of Rev   $ % of Rev   $ % of Rev   $ % of Rev
GAAP Gross Profit $ 380.4     42.8 %   $ 285.0     42.1 %   $ 1,266.2     42.4 %   $ 1,094.4     42.8 %
Plant Conversion Expenses   0.5     0.1 %     0.4     0.1 %     1.5     0.1 %     2.9     0.1 %
Non-GAAP Gross Profit $ 380.9     42.9 %   $ 285.4     42.2 %   $ 1,267.7     42.5 %   $ 1,097.3     42.9 %

(2) In accordance with GAAP, reported Gross Profit includes the impact of the items identified in this table. For internal purposes, including the determination of management compensation, the Company excludes these items from results when evaluating operating performance.

This table and the Company’s internal use of non-GAAP Gross Profit are not intended to imply, and should not be interpreted as implying, that non-GAAP Gross Profit is a better measure of performance than GAAP Gross Profit.

Table to reconcile GAAP EPS to Non-GAAP EPS(3)

  Three Months Ended December 31,   Years Ended December 31,
      Change       Change
    2015     2014   $ %     2015     2014   $ %
GAAP EPS $   0.80   $   0.96   $ (0.16 )   (16.4 )%   $   2.96   $   3.79   $ (0.82 )   (21.7 )%
Acquisition Expenses a   0.00     0.03           0.34     0.14      
Integration Expenses a   0.15     0.08           0.39     0.19      
Litigation Expenses a   0.05     0.02           0.46     0.05      
Changes in Fair Value of Contingent
  Consideration a
--   (0.06 )         (0.01 )   (0.02 )    
Impairment of intangible assets a   0.02   --         0.02   --    
Plant Conversion and Restructuring
  Expenses a
  0.04     0.09           0.18     0.12      
Add Back Convertible Preferred
  Stock Dividend b
  0.12   --         0.14   --    
Reallocation of EPS Related to
  Convertible Preferred Stock If-
  Converted Method b
  (0.07 ) --         (0.08 ) --    
Non-GAAP EPS (Adjusted) $   1.11   $   1.12   $ (0.01 )   (0.9 )%   $   4.40    $   4.27   $   0.13     3.0 %
Diluted Weighted Average Number
  of Common Shares Outstanding
  Under If-Converted Method
  91,430,668     86,194,513           87,810,927     86,233,612      

(3a) In accordance with GAAP, reported earnings per diluted share (EPS) include the after-tax impact of the items identified. For internal purposes, including the determination of management compensation, the Company excludes these items from results when evaluating operating performance.

(3b) For purposes of determining non-GAAP EPS, the Company (1) adds back the mandatory convertible preferred stock dividend; and (2) deducts the EPS impact of the items identified above and the mandatory convertible preferred stock dividend using the “if-converted” method.  Under the “if-converted” method used in determining our non-GAAP EPS, the items identified above and the preferred dividend applicable to the convertible preferred stock is added back to net income attributable to Stericycle, the numerator. The Mandatory Convertible Preferred shares are assumed to be converted to common shares at the beginning of the period or, if later, at the time of issuance, and the resulting common shares are included in the denominator.

This table and the Company’s internal use of non-GAAP earnings per diluted share are not intended to imply, and should not be interpreted as implying, that non-GAAP earnings per diluted share is a better measure of performance than GAAP earnings per diluted share.

Cash flow from operations was $390.3 million and $448.5 million for the full years of 2015 and 2014, respectively.

For more information about Stericycle, please visit our website at www.stericycle.com.

Safe Harbor Statement: This press release may contain forward-looking statements that involve risks and uncertainties, some of which are beyond our control (for example, general economic and market conditions). Our actual results could differ significantly from the results described in the forward-looking statements. Factors that could cause such differences include changes in governmental regulation of the collection, transportation, treatment and disposal of regulated waste or the proper handling and protection of personal and confidential information, increases in transportation and other operating costs, the level of governmental enforcement of regulations governing regulated waste collection and treatment or the proper handling and protection of personal and confidential information, our obligations to service our substantial indebtedness and to comply with the covenants and restrictions contained in our private placement notes, term loan credit facility and revolving credit facility, our ability to execute our acquisition strategy and to integrate acquired businesses, competition and demand for services in the regulated waste and secure information destruction industries, political, economic and currency risks related to our foreign operations, impairments of goodwill or other indefinite-lived intangibles, variability in the demand for services we provide on a project or non-recurring basis, exposure to environmental liabilities, fluctuations in the price we receive for the sale of paper, disruptions in or attacks on our information technology systems, compliance with existing and future legal and regulatory requirements, as well as other factors described in our filings with the U.S. Securities and Exchange Commission, including our most recently filed Annual Report on Form 10-K. As a result, past financial performance should not be considered a reliable indicator of future performance, and investors should not use historical trends to anticipate future results or trends. We make no commitment to disclose any subsequent revisions to forward-looking statements.

FOR FURTHER INFORMATION CONTACT:

Investor Relations 847-607-2012

Conference call to be held February 4, 2016 4:00 p.m. Central time – Dial 866-516-6872 at least 5 minutes before start time. If you are unable to participate on the call, a replay will be available through March 4th by dialing 855-859-2056, access code 21498985. To hear a live simulcast of the call or access the audio archive, visit the investor relations page on www.stericycle.com.

STERICYCLE, INC. AND SUBSIDIARIES  
CONDENSED CONSOLIDATED BALANCE SHEETS  
(IN THOUSANDS)  
(UNAUDITED)  
             
    December 31,  
      2015         2014    
ASSETS            
Current Assets:            
Cash and cash equivalents $   55,634     $   22,236    
Short-term investments     69         380    
Accounts receivable, net     614,494         465,473    
Prepaid expenses     46,740         30,632    
Other current assets     44,891         33,173    
Total Current Assets     761,828         551,894    
Property, plant and equipment, net     665,602         460,408    
Goodwill     3,676,326         2,418,832    
Intangible assets, net     1,833,561         909,645    
Other assets     43,553         32,523    
Total Assets $   6,980,870     $   4,373,302    
             
LIABILITIES AND EQUITY            
Current Liabilities:            
Current portion of long-term debt $   161,409     $   131,969    
Accounts payable     149,202         114,596    
Accrued liabilities     196,087         131,743    
Deferred revenues     16,989         21,624    
Other current liabilities     64,105         60,975    
Total Current Liabilities     587,792         460,907    
Long-term debt, net of current portion     3,052,639         1,527,246    
Deferred income taxes     517,587         403,847    
Other liabilities     76,667         64,117    
Equity:            
Mandatory convertible preferred stock     8         -    
Common stock     849         849    
Additional paid-in capital     1,141,999         289,211    
Accumulated other comprehensive loss     (282,632 )       (138,419 )  
Retained earnings     1,868,014         1,743,371    
Total Stericycle, Inc. Equity     2,728,238         1,895,012    
Noncontrolling interests     17,947         22,173    
Total Equity     2,746,185         1,917,185    
Total Liabilities and Equity $   6,980,870     $   4,373,302    

 

STERICYCLE, INC. AND SUBSIDIARIES  
 CONDENSED CONSOLIDATED STATEMENTS OF INCOME  
(IN THOUSANDS, EXCEPT SHARES AND PER SHARE DATA)  
(UNAUDITED)  
             
  Three Months Ended     Years Ended  
    December 31,     December 31,  
    2015         2014         2015         2014    
  $ % of Rev     $ % of Rev     $ % of Rev     $ % of Rev  
             
Revenues $   888,304     100.0 %   $   676,947     100.0 %   $   2,985,908     100.0 %   $   2,555,601     100.0 %  
Cost of revenues ("COR") exclusive of depreciation                                
and adjusting items shown below     488,523     55.0 %       378,182     55.9 %       1,656,573     55.5 %       1,401,797     54.9 %  
Depreciation     18,919     2.1 %       13,415     2.0 %       61,642     2.1 %       56,478     2.2 %  
Total cost of revenues     507,442     57.1 %     391,597     57.8 %       1,718,215     57.5 %     1,458,275     57.1 %  
                             
Gross profit (non-GAAP)     380,862     42.9 %       285,350     42.2 %       1,267,693     42.5 %       1,097,326     42.9 %  
                               
Selling, general and administrative expenses ("SG&A")                                
exclusive of depreciation, amortization and adjusting                                
items shown below     177,556     20.0 %       112,563     16.6 %       539,944     18.1 %       433,865     17.0 %  
Depreciation     7,519     0.8 %       3,121     0.5 %       20,272     0.7 %       15,446     0.6 %  
Amortization     18,541     2.1 %       8,478     1.3 %       45,498     1.5 %       32,692     1.3 %  
Total SG&A expense     203,616     22.9 %       124,162     18.3 %       605,714     20.3 %       482,003     18.9 %  
                               
Income from operations (non-GAAP) exclusive of                      
adjusting items shown below     177,246     20.0 %       161,188     23.8 %       661,979     22.2 %       615,323     24.1 %  
                       
Adjusting items:                                
Plant conversion expenses (COR)     507     0.1 %     381     0.1 %       1,508     0.1 %     2,915     0.1 %  
Acquisition expenses (SG&A)     (818 )   -0.1 %     2,661     0.4 %       39,138     1.3 %     13,333     0.5 %  
Integration expenses (SG&A)     20,432     2.3 %       11,343     1.7 %       51,689     1.7 %       25,968     1.0 %  
Change in fair value of contingent consideration (SG&A)     -     0.0 %       (5,405 )   -0.8 %       (640 )   0.0 %       (1,452 )   -0.1 %  
Impairment of intangible assets (SG&A)     1,781     0.2 %       -     0.0 %       1,781     0.1 %       -     0.0 %  
Restructuring and plant conversion expenses (SG&A)     4,160     0.5 %       10,114     1.5 %       21,240     0.7 %       11,649     0.5 %  
Litigation expenses (SG&A)     645     0.1 %       3,331     0.5 %       59,651     2.0 %       6,574     0.3 %  
                               
Income from operations (GAAP)     150,539     16.9 %       138,763     20.5 %       487,612     16.3 %       556,336     21.8 %  
                               
Other income (expense):                                
Interest expense, net     (24,908 )   -2.8 %       (18,139 )   -2.7 %       (77,274 )   -2.6 %       (66,022 )   -2.6 %  
Other income/ (expense), net     4,525     0.5 %       (1,177 )   -0.2 %       569     0.0 %       (2,746 )   -0.1 %  
                               
Total other expense     (20,383 )   -2.3 %       (19,316 )   -2.9 %       (76,705 )   -2.6 %       (68,768 )   -2.7 %  
                               
Income before income taxes     130,156     14.7 %       119,447     17.6 %       410,907     13.8 %       487,568     19.1 %  
                               
Income tax expense     51,537     5.8 %       36,789     5.4 %       142,862     4.8 %       159,422     6.2 %  
                               
Net income     78,619     8.9 %       82,658     12.2 %       268,045     9.0 %       328,146     12.8 %  
                               
Less: net (loss)/ income attributable to noncontrolling interests     (289 )   0.0 %       132     0.0 %       967     0.0 %       1,690     0.1 %  
                               
Net income attributable to Stericycle, Inc.     78,908     8.9 %       82,526     12.2 %       267,078     8.9 %       326,456     12.8 %  
                               
Less: mandatory convertible preferred stock dividend     10,107     1.1 %       -     0.0 %       11,791     0.4 %       -     0.0 %  
                               
Net income attributable to Stericycle, Inc.                                
Common Shareholders $   68,801     7.7 %   $   82,526     12.2 %   $   255,287     8.5 %   $   326,456     12.8 %  
                               
Earnings per share - diluted $   0.80       $   0.96       $   2.96       $   3.79      
                               
Weighted average number of                                
common shares outstanding - diluted     85,949,461           86,194,513           86,162,609           86,233,612      

 

STERICYCLE, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(IN THOUSANDS)
(UNAUDITED)
           
     
    December 31,
      2015         2014  
Operating Activities:          
Net income $   268,045     $   328,146  
Adjustments to reconcile net income to net cash          
provided by operating activities:          
Stock compensation expense     21,750         17,773  
Excess tax benefit of stock options exercised     (16,897 )       (17,906 )
Depreciation     81,914         71,924  
Amortization     45,498         32,692  
Deferred income taxes     (6,715 )       16,550  
Other, net     7,467         8,932  
Changes in operating assets and liabilities, net of          
effect of acquisitions:          
Accounts receivable     (55,890 )       (34,116 )
Accounts payable     26,366         (5,712 )
Accrued liabilities     23,133         21,279  
Deferred revenue     (4,615 )       1,017  
Other assets and liabilities     294         7,921  
           
Net cash provided by operating activities     390,350         448,500  
           
Investing Activities:          
Payments for acquisitions, net of cash acquired     (2,419,437 )       (374,321 )
Proceeds from/ (purchases of) investments     294         (1,957 )
Capital expenditures     (114,761 )       (86,496 )
           
Net cash used in investing activities     (2,533,904 )       (462,774 )
           
Financing Activities:          
Repayments of long-term debt and other obligations     (93,172 )       (101,231 )
Proceeds from foreign bank debt     53,747         205,086  
Repayments of foreign bank debt     (87,308 )       (193,284 )
Proceeds from term loan     1,550,000         -  
Repayments of term loan     (300,000 )       -  
Proceeds from private placement of long-term note     600,000         -  
Repayments of private placement of long-term note     (100,000 )       -  
Proceeds from senior credit facility     1,907,402         1,413,026  
Repayments of senior credit facility     (2,004,385 )       (1,216,031 )
Repayments of capital lease obligations     (3,865 )       (5,826 )
Payments of deferred financing costs     (9,903 )       (2,280 )
Payment for hedge     (8,833 )       -  
Purchases and cancellations of treasury stock     (130,576 )       (194,066 )
Proceeds from issuance of mandatory convertible preferred stock     746,900         -  
Dividends paid on mandatory convertible preferred stock     (10,106 )       -  
Proceeds from issuances of common stock     60,124         51,852  
Excess tax benefit of stock options exercised     16,897         17,906  
Payments to noncontrolling interests     (5,714 )       (5,201 )
           
Net cash provided by/ (used in) financing activities     2,181,208         (30,049 )
Effect of exchange rate changes on cash     (4,256 )       (608 )
Net increase/ (decrease) in cash and cash equivalents     33,398         (44,931 )
Cash and cash equivalents at beginning of period     22,236         67,167  
           
Cash and cash equivalents at end of period $   55,634     $   22,236  
           
Non-cash activities:          
Net issuance of obligations for acquisitions $   80,189     $   145,938  


Primary Logo